OQROGet OQRO Pro
Insider trade

Johnson & Johnson (JNJ)Officer sold ~$4.19M

John C Reed, Officer at Johnson & Johnson, sold ~$4.19M of Johnson & Johnson shares.

~$4.19M
Approx. value · 22K sh @ $192.71
11K
Holds after · shares reported
Traded
Oct 17, 2025
Filed
Oct 20, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 15, 2023CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  2. Sep 26, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  3. Oct 29, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  4. Mar 19, 2025CongressDisclosed sale of JNJ — reported range $15,001 - $50,000
  5. Jul 31, 2025CongressDisclosed partial sale of JNJ — reported range $15,001 - $50,000
  6. Aug 4, 2025Congress · 1 personMembers of Congress: 2 purchases
  7. Aug 14, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  8. Aug 15, 2025InsiderCFO sold ~$2.98M of JNJ shares in the open market
  9. Aug 19, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  10. Aug 22, 2025InsiderCEO sold ~$22.5M of JNJ shares in the open market
  11. Sep 4, 2025Insider · 4 days before an 8-KOfficer sold ~$10M of JNJ shares in the open market
  12. Sep 8, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 8, 2025, Johnson & Johnson (the Company) announced that John Morikis was elected to the Board of Directors. The Board has determined that Mr. Morikis satisfies the applicable independence requirements of the NYSE Listed Company Manual.”
  13. Sep 23, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  14. Oct 9, 2025Federal contract · $19K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $19K obligated to date
  15. Oct 10, 2025Congress · 1 personMembers of Congress: 2 sales
  16. Oct 14, 2025Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  17. Oct 16, 2025Federal contract · $384K obligatedDepartment of Defense awarded Johnson & Johnson: $384K obligated to date
  18. Oct 17, 2025 · this disclosureInsiderOfficer sold ~$4.19M of JNJ shares in the open market

What came next

  1. Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
  2. Oct 31, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  3. Nov 5, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  4. Nov 6, 2025Insider10% owner sold ~$534K of JNJ shares in the open market
  5. Nov 7, 2025Insider10% owner sold ~$2K of JNJ shares in the open market
  6. Nov 12, 2025Insider10% owner sold ~$10K of JNJ shares in the open market
  7. Nov 13, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  8. Nov 20, 2025CongressDisclosed partial sale of JNJ — reported range $15,001 - $50,000
  9. Nov 21, 2025Insider10% owner sold ~$5K of JNJ shares in the open market
  10. Nov 24, 2025Insider10% owner sold ~$22K of JNJ shares in the open market
  11. Nov 25, 2025Insider10% owner sold ~$160K of JNJ shares in the open market
  12. Nov 26, 2025Insider · 2 peopleInsiders: 1 purchase (~$258K), 1 sale (~$64K)
  13. Dec 4, 2025FDARecall: Impella 5.5 with SmartAssist¿ S2, Impella 5.5 with SmartAssist S2 Set, AU.
  14. Dec 9, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  15. Dec 10, 2025Federal contract · $8K obligatedDepartment of Defense awarded Johnson & Johnson: $7.7K obligated to date
  16. Dec 12, 2025FDAFDA drug approval: Akeega
  17. Dec 15, 2025FDAFDA device approval: ETHIZIA
  18. Dec 17, 2025FDAFDA drug approval: Rybrevant Faspro
  19. Dec 17, 2025FDAFDA device clearance: ETHICON™ 4000 45mm Compact Stapler (EC3DT45C); ETHICON™ 4000 45mm Standard Stapler (EC3DT45S); ETHICON™ 4000 45mm Long Stapler (EC3DT45L); ETHICON™ 3D 45mm Whi…
  20. Dec 18, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 15 insider filings (SEC Form 4 or Form 144), 8 Congress trade reports, 167 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

Other recent filings by John C Reed, EVP, Innovative Medicine, R&D

The full history of John C Reed, EVP, Innovative Medicine, R&D is on the profile page.

How this filing works

Other disclosures at Johnson & Johnson

Everything OQRO holds on this company is on its JNJ page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data